Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

This paper proposes the design of combination opioid–adrenergic tethered compounds to enhance efficacy and specificity, lower dosage, increase duration of activity, decrease side effects, and reduce risk of developing tolerance and/or addiction. Combinations of adrenergic and opioid drugs are someti...

Descripción completa

Detalles Bibliográficos
Autor principal: Root-Bernstein, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876737/
https://www.ncbi.nlm.nih.gov/pubmed/35215326
http://dx.doi.org/10.3390/ph15020214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876737/
https://www.ncbi.nlm.nih.gov/pubmed/35215326
http://dx.doi.org/10.3390/ph15020214

Ejemplares similares